Capsy 500 mg Tablet

Capecitabine belongs to a class of chemotherapy medications known as antimetabolites, and it works as a prodrug, meaning it is converted into its active form, 5-fluorouracil, specifically within tumor tissue. This targeted conversion helps interfere with the DNA synthesis process that cancer cells need to grow and divide, ultimately slowing the progression of the disease. It is commonly used in the treatment of colorectal cancer and breast cancer, often as part of a broader treatment plan that may include other chemotherapy agents, radiation, or surgery. One of the key advantages of Capecitabine is that it is taken orally, offering a more convenient alternative to intravenous chemotherapy for many patients, allowing treatment to take place largely at home between clinical check-ins. The medication is typically taken in cycles, with specific dosing schedules that include treatment days followed by rest periods, as determined by an oncologist based on the specific cancer type and stage. Regular monitoring, including blood tests, is an important part of treatment to help track the body's response and guide any necessary dose adjustments. Many patients experience meaningful tumor response and improved disease management as part of a comprehensive cancer treatment plan involving Capecitabine. Close communication with the oncology care team throughout treatment helps address any side effects and supports the best possible outcomes. As with all chemotherapy medications, Capecitabine tablets should be used strictly under the guidance of an experienced oncology healthcare provider.